Evidence map›Paper›PMID 22436120›Full record

ReviewJournal of cellular and molecular medicine2012

Tissue engineering and regenerative medicine -where do we stand?

Raymund E Horch, Ulrich Kneser, Elias Polykandriotis, Volker J Schmidt, Jiaming Sun, Andreas Arkudas

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Journal of cellular and molecular medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04001842 (Mandibular Reconstruction Using Tissue Regeneration With Axially Vascularised Bone Substitutes), which is not on this map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04001842 narecruitingnot on this mapstarted 2019, after this paper: background citation

Mandibular Reconstruction Using Tissue Regeneration With Axially Vascularised Bone Substitutes

TypeinterventionalSponsorUniversity of AlexandriaRan2019 to 2030Enrolled10ConditionsMandibular DeficiencyArmsSurgical reconstruction of the mandible using an axially vascularized bone construct
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Identification and protective role of CD34Histochemistry and cell biology · 2023
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Telocytes and Their Extracellular Vesicles-Evidence and Hypotheses.International journal of molecular sciences · 2016
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Telocytes in regenerative medicine.Journal of cellular and molecular medicine · 2015
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Successful human long-term application of in situ bone tissue engineering.Journal of cellular and molecular medicine · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Raymund E HorchDepartment of Plastic and Hand Surgery And Laboratory for Tissue Engineering and Regenerative Medicine, Friedrich Alexander University Erlangen-Nuernberg, Erlangen, Germany. raymund.horch@uk-erlangen.de
Ulrich Kneser
Elias Polykandriotis
Volker J Schmidt
Jiaming Sun
Andreas Arkudas
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEWuhan Union Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tissue Engineering (TE) in the context of Regenerative Medicine (RM) has been hailed for many years as one of the most important topics in medicine in the twenty-first century. While the first clinically relevant TE efforts were mainly concerned with the generation of bioengineered skin substitutes, subsequently TE applications have been continuously extended to a wide variety of tissues and organs. The advent of either embryonic or mesenchymal adult stem-cell technology has fostered many of the efforts to combine this promising tool with TE approaches and has merged the field into the term Regenerative Medicine. As a typical example in translational medicine, the discovery of a new type of cells called Telocytes that have been described in many organs and have been detected by electron microscopy opens another gate to RM. Besides cell-therapy strategies, the application of gene therapy combined with TE has been investigated to generate tissues and organs. The vascularization of constructs plays a crucial role besides the matrix and cell substitutes. Therefore, novel in vivo models of vascularization have evolved allowing axial vascularization with subsequent transplantation of constructs. This article is intended to give an overview over some of the most recent developments and possible applications in RM through the perspective of TE achievements and cellular research. The synthesis of TE with innovative methods of molecular biology and stem-cell technology appears to be very promising.

Indexed as

Adult Stem CellsAnimalsGenetic TherapyGene Transfer TechniquesHumansMesenchymal Stem CellsRegenerative MedicineTissue EngineeringTranslational Research, Biomedical

Identifiers

PMID22436120
PMCPMC3823070
OpenAlexW2046725871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.